Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components
Open Access
- 1 January 2015
- journal article
- research article
- Published by Medknow in Journal of Research in Medical Sciences
- Vol. 20 (8) , 763-770
Abstract
Background: Multiple factors are involved in the development and progression of type 2 diabetes mellitus (DMII) to DMII with metabolic syndrome (MetS) and cardiovascular complications. To identify some of these factors, we aim to investigate the changes in erythrocyte membrane Na + /K + -ATPase activity, serum glucose, insulin, lipid profile, hemoglobin A1C (HbA1c), high-sensitivity C-reactive protein (hs-CRP), anthropometric measurements, and blood pressure in DMII with and without MetS. Materials and Methods: This cross-sectional study comprised 155 male subjects distributed into three groups as healthy controls (50 non-DMII volunteers), Group I (50 DMII without MetS), and Group II (55 DMII with MetS). Fasting blood samples were taken for the measurement of glucose, insulin, HbA1c, hs-CRP and lipid profile. Na + /K + -ATPase activity was determined in erythrocyte ghost. Results: Na + /K + -ATPase activity was significantly decreased in DMII groups compared with controls. No significant difference was shown in Na + /K + -ATPase activity between DMII groups. Total ATPase activity, total cholesterol and low-density lipoprotein-cholesterol levels were similar in the three groups. Levels of insulin, hs-CRP, triacylglycerols, systolic blood pressure, weight, waist and hip circumference, waist/hip ratio, and body mass index were significantly elevated and high-density lipoprotein-cholesterol significantly decreased only in Group II. Significant differences in serum glucose and hip circumference were seen between the groups. No significant differences in HbA1c levels were observed between DMII groups. Conclusion: Changes in many of the measured risk factors that occurred only in Group II compared with controls and Group I may provide an explanation of how DMII progresses to DMII with MetS and future cardiovascular complications.Keywords
This publication has 32 references indexed in Scilit:
- Pathophysiology of diabetic dyslipidaemia: where are we?Diabetologia, 2015
- Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 DiabetesDiabetes, 2015
- Increased Adipose Tissue Insulin Resistance in Metabolic Syndrome: Relationship to Circulating AdipokinesMetabolic Syndrome and Related Disorders, 2014
- Microvascular and macrovascular complications in children and adolescentsPediatric Diabetes, 2014
- Baseline Levels, and Changes Over Time in Body Mass Index and Fasting Insulin, and Their Relationship to Change in Metabolic Trait ClusteringMetabolic Syndrome and Related Disorders, 2014
- Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?World Journal of Diabetes, 2014
- Association between erythrocyte Na+K+-ATPase activity and some blood lipids in type 1 diabetic patients from Lagos, NigeriaBMC Endocrine Disorders, 2007
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Interactions between insulin resistance and insulin secretion in the development of glucose intoleranceJournal of Clinical Investigation, 2000